Revenue Recognition Segment revenue by major payor (Tables)

3 Months Ended

Mar. 31, 2023

Revenues by major payor [Abstract]

Disaggregation of Revenue [Table Text Block]

The following tables summarize the Company's segment revenues by primary payor source:

	Three months ended March 31, 2023						Three months ended March 31, 2022
	U.S. dialysis		Other — Ancillary services		Consolidated		U.S. dialysis		Other — Ancillary services		Consolidated
Dialysis patient service revenues:
Medicare and Medicare Advantage	$	1,482,767	$		$	1,482,767	$	1,464,086	$		$	1,464,086
Medicaid and Managed Medicaid	205,776				205,776		189,655				189,655
Other government	82,044		121,585		203,629		80,800		116,895		197,695
Commercial	835,393		54,516		889,909		834,579		52,425		887,004
Other revenues:
Medicare and Medicare Advantage			93,238		93,238				83,596		83,596
Medicaid and Managed Medicaid			570		570				538		538
Commercial			1,206		1,206				1,338		1,338
Other(1)	6,180		12,839		19,019		5,976		9,836		15,812
Eliminations of intersegment revenues	(22,047)		(1,368)		(23,415)		(22,169)				(22,169)
Total	$	2,590,113	$	282,586	$	2,872,699	$	2,552,927	$	264,628	$	2,817,555

(1)    Other primarily consists of management service fees earned in the respective Company line of business as well as other non-patient service revenue from the Company's U.S. integrated kidney care (IKC) and other ancillary services and international operations.